|
1 |
Change to the Guidance Entitled "Revised Precautionary Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) by Blood and Blood Products" Federal Drug Administration Center for Biologics Evaluation & Research September 08, 1998
|
110 |